Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

WS2 - Viral Genetics

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.

DNA

Work strand 2 virus

Work Strand 2 focuses on stratification through assessment of the HCV viral genome

The contribution of viral genetic elements in HCV treatment response and disease progression is poorly understood. However, recent developments in sequencing methods and bioinformatics, provides an opportunity to undertake complete genome characterisation of viral populations within HCV infected individuals.

Methods to identify naturally occurring and treatment induced mutations in HCV, which influence their response to therapy, also represents a vital component in HCV stratification.

The overall objectives of this Work Strand are to identify the viral genomic determinants that predict treatment response and the development of liver complications (in particular cancer) and to investigate drug sensitivity of various viral genotypes. 

This Work Strand is led by Professor Peter Simmonds (University of Oxford).